Inventor · disambiguated record
William Jia
Also filed as: JIA WILLIAM · JIA WILLIAM WEI-GUO
4 granted patents·12 pending applications·11 citations·filing 2001–2024
64Inventor score
Files withVIROGIN BIOTECH CANADA LTD13JIA WILLIAM1UNIV BRITISH COLUMBIA1VIROGIN BIOTECH SHANGHAI LTD1
Top patents by PatentIndex Score
16 records- 0171US6759397B2Ginsenoside chemotherapyUNIV BRITISH COLUMBIA·Filed 2001·Granted Jul 6, 2004·11 cites·21 claims
- 0268US2025243252A1Oncolytic herpes simplex virus vectors expressing immune system-stimulatory moleculesVIROGIN BIOTECH CANADA LTD·Filed 2024·Application pending·0 cites
- 0361US2025304999A1Genetically modified enterovirus vectors with enhanced genomic stabilityVIROGIN BIOTECH CANADA LTD·Filed 2023·Application pending·0 cites
- 0461US2023365994A1Hsv vectors with enhanced replication in cancer cellsVIROGIN BIOTECH CANADA LTD·Filed 2023·Application pending·0 cites
- 0558US2022096578A1Compositions and methods of using stat1/3 inhibitors with oncolytic herpes virusVIROGIN BIOTECH CANADA LTD·Filed 2021·Application pending·0 cites
- 0656US2025161384A1Transcriptional and translational dual regulated oncolytic herpes simplex virus vectorsVIROGIN BIOTECH SHANGHAI LTD·Filed 2023·Application pending·0 cites
- 0753US12162919B2Oncolytic herpes simplex virus vectors expressing immune system-stimulatory moleculesVIROGIN BIOTECH CANADA LTD·Filed 2017·Granted Dec 10, 2024·0 cites·18 claims
- 0852US11384119B2Compositions and methods for inhibiting CD279 interactionsVIROGIN BIOTECH CANADA LTD·Filed 2020·Granted Jul 12, 2022·0 cites·3 claims
- 0944US2022267799A1Genetically modified enterovirus vectorsVIROGIN BIOTECH CANADA LTD·Filed 2020·Application pending·0 cites
- 1040US10590169B2Compositions and methods for inhibiting CD279 interactionsVIROGIN BIOTECH CANADA LTD·Filed 2016·Granted Mar 17, 2020·0 cites·10 claims
- 1139US2019307820A1Compositions and methods of using stat1/3 inhibitors with oncolytic herpes virusVIROGIN BIOTECH CANADA LTD·Filed 2017·Application pending·0 cites
- 1239US2019106709A1Hsv vectors with enhanced replication in cancer cellsVIROGIN BIOTECH CANADA LTD·Filed 2017·Application pending·0 cites
- 1339US2021046130A1Recombinant viral vaccinesVIROGIN BIOTECH CANADA LTD·Filed 2019·Application pending·0 cites
- 1434US2020171110A1Hsv vector with reduced neurotoxicityVIROGIN BIOTECH CANADA LTD·Filed 2019·Application pending·0 cites
- 1534US2021177921A1Targeting moiety-decorated oncolytic virusesVIROGIN BIOTECH CANADA LTD·Filed 2018·Application pending·0 cites
- 1633US2017319639A1Oncolytic viruses & methods of use thereofJIA WILLIAM·Filed 2017·Application pending·0 cites
Join the waitlist — get patent alerts
Get an alert when William Jia files or is granted a new patent.
We store only your email — no account needed. See our privacy policy.
Identity basis: PatentsView inventor disambiguation (2025Q4-odp release). How scoring works →